Forte Biosciences, Inc. - FBRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jul 16, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 3.2% | 655,199 | View |
| Jul 16, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 3.2% | 655,199 | View |
| Jul 16, 2026 | SCHEDULE 13G/A | Israel A. Englander | 3.2% | 655,199 | View |
| Jun 08, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.2% | 1,062,182 | View |
| Jun 08, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.2% | 1,062,182 | View |
| Jun 08, 2026 | SCHEDULE 13G | Israel A. Englander | 5.2% | 1,062,182 | View |
| May 15, 2026 | SCHEDULE 13G | MPM BioImpact LLC | 7.2% | 1,000,682 | View |
| May 15, 2026 | SCHEDULE 13G/A | ORBIMED ADVISORS LLC | 4.3% | 884,230 | View |
| May 15, 2026 | SCHEDULE 13G/A | ORBIMED CAPITAL LLC | 1.5% | 312,725 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Alger Associates, Inc. | 10.2% | 624,286 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 9.99% | 1,387,178 | View |
| May 14, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 7.3% | 1,011,890 | View |
| May 14, 2026 | SCHEDULE 13G/A | Michael Cho | 7.3% | 1,011,890 | View |
| May 13, 2026 | SCHEDULE 13G | Adage Capital Management, L.P. | 6.84% | 950,000 | View |
| May 13, 2026 | SCHEDULE 13G | Robert Atchinson | 6.84% | 950,000 | View |
| May 13, 2026 | SCHEDULE 13G | Phillip Gross | 6.84% | 950,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 11.4% | 1,425,785 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 6.7% | 834,964 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Michael Cho | 6.7% | 834,964 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.